Company Search:
Advanced Search
Sponsored Links
Akorn, Inc. Company Snapshot
Akorn, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Akorn with three other pharmaceutical manufacturers in North America: 3sbio Inc (2019 sales of $770.80 million of which 100% was Biopharmaceuticals), Lannett Company, Inc. ($655.41 million of which 30% was Thyroid Deficiency), and Indivior Plc ($785.00 million of which 100% was Buprenorphine Based Drugs).

Sales Analysis. During the year ended December of 2019, sales at Akorn were $682.43 million. This is a decrease of 1.7% versus 2018, when the company's sales were $694.02 million. Contributing to the drop in overall sales was the 2.7% decline in Prescription Pharmaceuticals, from $620.67 million to $604.21 million. . However, these declines were partially offset by the increase in sales of Consumer Health (up 6.6% to $78.22 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Akorn, Inc.
  Stock Performance Chart for Akorn, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): .19
(Figures in U.S. Dollars)
1 Week -23.7%   13 Weeks -36.7%  
4 Weeks -23.6%   52 Weeks -93.7%  
Akorn, Inc. Key Data:
  Ticker: AKRXQ Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 682,429,000
(Year Ending Jan 2020).
Employees: 2,227
  Currency: U.S. Dollars Market Cap: 23,992,523
  Fiscal Yr Ends: December Shares Outstanding: 126,276,438
  Share Type: Common Closely Held Shares: 14,379,364
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.